Quickly verify claims by accessing the underlying experimental data and figures.
Press Enter β΅ to solve
Fuel Your Discoveries
"For me, it is far better to grasp the Universe as it really is than to persist in delusion, however satisfying and reassuring."
- Carl Sagan
Quick Explanation
Copied
Rapid critical summary
The authors present hiddenCOMET, a population-level hidden Markov / continuous-time Markov chain (CTMC) framework that links latent EMT states (E,H,M) to observed cell cycle fractions (G1,S,G2M) via an estimated emission matrix B and uses it to recover EMT trajectories from time-series cell-cycle data when direct EMT calling fails. The method is implemented in an R package plus Shiny app and validated on four cancer cell lines and multiple inducers (TGFΞ², EGF, TNFΞ±) with simulations demonstrating identifiability under reasonable sample sizes
Long Explanation
Paper Review: hiddenCOMET β Inferring EMT dynamics from cell cycle profiles using a hidden Markov framework
Primary claim: A three-state CTMC HMM that couples latent EMT states to observed cell-cycle phase fractions via an emission matrix can reconstruct EMT trajectories and estimate transition rates from time-series cell-cycle data when direct EMT-state calling is unreliable
What the paper does well
Formalizes EMT inference as a latent-state CTMC/HMM connecting a robust observable (cell-cycle fractions) to a fragile latent process (EMT), providing a clear mathematical pipeline (LS and MLE estimators, multinomial likelihood) and public software to reproduce analyses
Uses simulations to characterize identifiability (varying B entries, sample size N, noise) and demonstrates that with realistic sampling (hundredsβthousands of cells per timepoint) recovery is possibleβhelpful diagnostics for practitioners
Open-source R package hiddenCOMET plus web app (shiny) increases accessibility and reproducibility; repository documents inputs/usage and demo data which is excellent for method uptake
Main weaknesses and caveats
Fixed emission matrix across inducers: In the main analyses the emission matrix B is learned from TGFΞ² paired data and held fixed for EGF/TNFΞ± fits. The authors justify this as a cell-line specific coupling but acknowledge that inducer-specific emissions are plausible and that the fixed-B assumption may bias inferred Q rates if inducer changes alter how EMT maps to cell cycle (authors note this as future work)
Time-homogeneous CTMC simplifies biology: EMT induction is often time-varying and stimulus-dependent (dose, duration). Using a single Q ignores transient regime shifts (e.g., immediate signaling spikes) and could blur short fast transitionsβauthors constrained Q to [1e-5,5/day], and note several fitted rates hit bounds, indicating sampling resolution cannot resolve very fast transitions
Cell-line only, limited in vivo generalizability: All input datasets are cell lines; stromal and immune cells can confound cell-cycle signals in patient or tissue samples. The authors explicitly note potential confounding by stromal/immune cell populations and that generalization to mixed samples requires further study
Simplified 3-state EMT: The three-state coarse-grain (E,H,M) masks known heterogeneity of hybrid phenotypes; authors acknowledge lack of consensus on number of intermediate states and that richer multi-state models will need more data and likely better identifiability diagnostics
Growth/death and fractional sampling not modeled: The model assumes constant total cell count and does not include state-specific proliferation or death rates; differential growth could change observed fractions independent of state transitions (authors mention growth/death rates as future work)
Concrete suggestions to strengthen the work
Estimate B separately for each inducer where paired data exist and compare fits (test whether inducer-specific B materially changes Q estimates). If inducer-specific B improves multinomial likelihood markedly, avoid holding B fixed across treatments
Incorporate state-specific net growth terms (birth-death) into expected fractions model: Theta_t = B x_t where x_t evolves under both transitions and differential growth to separate proliferation effects from transitions; test identifiability via simulations similar to those already performed.
Collect higher temporal resolution (hours) for early timepoints to resolve fast transitionsβauthors report upper-bound hits consistent with dwell times <~3.3 hours for rates =5/day which are faster than their sampling intervals.
Validate on mixed-population datasets or spatially resolved transcriptomics (which can separate stromal vs tumor compartments) to test robustness to non-cancer cell contamination.
Reproducibility and software
The authors provide an R package (hiddenCOMET) and a Shiny app with demo data and example usage, and the GitHub repo documents core functions (estimate_B_ls, estimate_B_mle, fit_G_given_p0) and input formatsβthis is excellent for reproducibility. The simulation scripts used to produce identifiability diagnostics are included in the Rmd notebooks so others can reproduce the sensitivity experiments
Practical guidance for users
Minimum sampling: simulations show accuracy improves with N (cells per timepoint); practitioners should aim for at least several hundred to a few thousand cells per timepoint when using estimated B from similar contexts
If paired EMT/cell-cycle measurements exist for a given cell line and inducer, always estimate B from those paired data (MLE preferred with multinomial model when N is available) rather than borrowing B from another inducer.
Beware of parameters hitting bounds; if many rates hit the upper bound consider acquiring earlier sampling points or relaxing time-homogeneous assumptions.
Quick technical audit of key numbers provided
Example emission matrix used in simulations B0 = [[0.7,0.3,0.05],[0.2,0.5,0.25],[0.1,0.2,0.7]] (columns = E,H,M mapping to G1,S,G2M rows) β this matrix is coherent (columns sum to 1) and plausible biologically (epithelial high in S/G2M depending on cell line)
Generator matrix example Q = [[-0.2,0.2,0.0],[0.25,-0.47,0.22],[0.0,0.18,-0.18]] used in simulations; matrix exponentials yield valid P(t) used to generate cell-cycle fractions and multinomial sampling (methodologically sound)
Visualizations (interactive) β emission matrix and generator sanity checks
Conclusions and confidence
Overall this is a well-constructed, open, and useful methodological contribution: framing EMT inference as a latent-state identification problem tied to a robust observable is conceptually clean and practical, and the software release enables adoption. However, the strongest caveats are biological generalizability (cell lines only), the fixed-B across inducers assumption in primary fits, and the time-homogeneous CTMC simplification which together limit claims about in vivo EMT kinetics. The authors themselves clearly acknowledge these limitations and propose appropriate future directions including richer paired datasets, inducer-specific B estimation, adding growth/death modeling, and higher temporal resolution sampling
If you want I can: 1) run the hiddenCOMET R pipeline on the example data and replicate figures, 2) extend the model to include state-specific growth rates and test identifiability via simulations, or 3) compute inducer-specific B by re-analyzing paired datasets if you provide them. Click Run AI Biology Analysis to proceed.
Feedback:
Updated: December 08, 2025
BGPT Paper Review
Study Novelty
80%
The methodological idea of using an observed, robust secondary process (cell cycle fractions) to infer a context-specific latent process (EMT) via a CTMC/HMM is novel in this concrete, practical implementation and packaged software; it extends prior EMT trajectory methods (COMET) into a more general latent-observable framing and provides accessible tools.
Scientific Quality
80%
Solid mathematical formulation, careful simulation-based identifiability checks, and open-source code increase confidence. Limitations include reliance on fixed-B across inducers in main fits, time-homogeneous CTMC assumption, and only in vitro cell-line data; several fitted rates hit optimization bounds indicating identifiability limits at sampling resolution.
Study Generality
70%
The modeling framework (latent CTMC + emission matrix to observed compositional data) is generalizable to other latent processes paired with robust observables, but biological generality (in vivo tissues, mixed samples) is limited by current validation on cell lines.
Study Usefulness
80%
Provides a practical route to salvage EMT information when direct inference fails, with usable software; useful for labs with time-course cell-cycle data and limited EMT signal. Usefulness reduces when samples contain stroma/immune mixtures or when inducer-specific emissions are important.
Study Reproducibility
90%
High reproducibility: code, Rmd notebooks, simulation scripts, and a Shiny app are provided in the public GitHub repository allowing other researchers to rerun estimations and simulations; methods are described with explicit formulae for LS and MLE.
Explanatory Depth
80%
Provides mechanistic/statistical linkage between EMT latent transitions and observable cell-cycle composition using CTMC mathematics, matrix exponential propagation, multinomial likelihood, and identifiability simulations; limited by not modeling proliferation/death and temporal nonstationarity.
Preparing/validating hiddenCOMET inputs, running simulations, and computing identifiability diagnostics using the published emission and generator matrices to reproduce figures and test extensions.
Get emailed when your analysis is done!
We'll email you the results when your analysis is finished.
Hypothesis Graveyard
Hypothesis that a single universal B exists across all cell lines and inducers is implausibleβthe paper's own results show cell-line specificity and the authors warn against overgeneralization.
Hypothesis that 3-state EMT is sufficient for all systems is likely false for tissues with multiple stable hybrid subtypes; expanding states may be required but will need more data for identifiability.